Advertisement

HindustanTimes Sun,31 Aug 2014

Pfizer says keen to engage with AstraZeneca board

Reuters  London, May 13, 2014
First Published: 11:49 IST(13/5/2014) | Last Updated: 11:52 IST(13/5/2014)

US drugmaker Pfizer kept up the pressure on bid target AstraZeneca on Tuesday, saying its offer represented compelling value for a company which would otherwise face challenges as a standalone firm.

Pfizer released a statement to set out its case for the deal, just hours before its chief executive appears in front of a British parliamentary committee to explain why he wants to acquire Britain's second largest drugmaker.

AstraZeneca has rejected a $106 billion bid from Pfizer but the US group is widely expected to return with a higher offer later this week.


Advertisement
more from Business

India better prepared for eventual Fed rate hike, says RBI chief

India is better prepared to handle the impact of interest rate increases in the US as foreign funds are less likely to desert the country due to signs of an upturn in economic growth, its central bank chief said in an interview published Sunday.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved